In South Korea, the use of cardiovascular system medicine is anticipated to witness consistent growth from 2024 to 2028. The Defined Daily Dosage (DDD) per thousand persons per day is expected to increase steadily. In 2023, the usage stood at 285.6 units. Forecast data indicates that there will be a noticeable annual increase in DDD: 5.5% in 2024, 5.2% in 2025, 4.9% in 2026, 4.6% in 2027, and 4.4% in 2028.
Year-on-year variations:
- 2024: 5.5%
- 2025: 5.2%
- 2026: 4.9%
- 2027: 4.6%
- 2028: 4.4%
Over the five-year period, the Compound Annual Growth Rate (CAGR) is projected to be 4.9%, highlighting a steady upward trend in the consumption of cardiovascular medications.
Future trends to watch for:
- Advancements in cardiovascular treatments and new drug introductions could further affect the growth rate.
- Demographic changes, such as the aging population in South Korea, may increase the prevalence of cardiovascular conditions, driving higher medication usage.
- Government policies and healthcare initiatives aimed at preventing cardiovascular diseases could also impact long-term usage trends.